Company: BSTZ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049659
Chunk: 48

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 48
---
 (continued) December 31, 2024 BlackRock Health Sciences Trust (BME)

For the period ended December 31, 2024, the effect of derivative financial instruments in the Statements of Operations was as follows:

|                                                          | CommodityContracts | CreditContracts | EquityContracts | ForeignCurrencyExchangeContracts | InterestRateContracts | OtherContracts |        Total |
| Net Realized Gain (Loss) from:                           |                    |                 |                 |                                  |                       |                |              |
| Options purchased(a)                                     | $—                 | $—              |        $(6,226) | $—                               | $—                    | $—             |     $(6,226) |
| Options written                                          | —                  | —               |      -7,907,613 | —                                | —                     | —              |   -7,907,613 |
|                                                          | $—                 | $—              |    $(7,913,839) | $—                               | $—                    | $—             | $(7,913,839) |
| Net Change in Unrealized Appreciation (Depreciation) on: |                    |                 |                 |                                  |                       |                |              |
| Options written                                          | $—                 | $—              |      $5,003,236 | $—                               | $—                    | $—             |   $5,003,236 |

| (a) | Options purchased are included in net realized gain (loss) from investments — 
 unaffiliated.                                                                 |

Average Quarterly Balances of Outstanding Derivative Financial Instruments

| Options:                                    |           |
| Average value of option contracts purchased |     $—(a) |
| Average value of option contracts written   | 5,489,276 |

| (a) | Derivative financial instrument not held at any quarter-end. The risk exposure table serves as an 
 indicator of activity during the period.                                                          |

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements. Derivative Financial Instruments — Offsetting as of Period End The Trust’s derivative assets and liabilities (by type) were as follows:

|                                                                                     | Assets | Liabilities |
| Derivative Financial Instruments                                                    |        |             |
| Options                                                                             | $—     |  $2,822,101 |
| Total derivative assets and liabilities in the Statements of Assets and Liabilities | —      |   2,822,101 |
| Derivatives not subject